RESEARCH
On the discounting of cannabis and money: Sensitivity to magnitude vs. delay
Abstract Background While using most drugs of abuse is associated with higher than control rates of delay discounting, cannabis use may be the exception. As such, between-commodity differences in delay discounting (i.e., money vs. cannabis) have not been thoroughly...
Sifting through the weeds: Relationships between cannabis use frequency measures and delay discounting
Abstract Background Delay Discounting (DD) relates to more frequent cannabis use, but results are variable, potentially because of variations in whether integrated or single-item measures are used, and whether the timeframe of measures is narrow or broad. Explicating...
Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder
Abstract Objective: Abstinence is rarely achieved in clinical trials for cannabis use disorder (CUD). Cannabis reduction is associated with functional improvement, but reduction endpoints have not been established, indicating a need to identify and validate clinically...
Correlates of continued cannabis use during pregnancy
Abstract Background Cannabis use is increasingly common among pregnant women despite concern that it may be linked to adverse maternal and infant outcomes. Determining whether variables associated with cannabis use predict whether women continue or quit using during...
The Effects of Cannabis Use Frequency and Episodic Specificity Training on the Recall of Specific and Rewarding Events
Center for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College, Lebanon, NH, United States Background: Growing evidence implicates subjective episodic memory, the retrieval of detailed, integrated, and personally relevant past events, as a...
Initial evaluation of domain-specific episodic future thinking on delay discounting and cannabis use
Sofis, M. J., Lemley, S. M., Jacobson, N. C., & Budney, A. J. (2021). Initial evaluation of domain-specific episodic future thinking on delay discounting and cannabis use. Experimental and Clinical Psychopharmacology. Advance online publication....
Persisting on the past: Cross-sectional and prospective associations between sunk cost propensity and cannabis use
Abstract Prevalence of cannabis use in the United States continues to rise, and 30% of cannabis users eventually meet criteria for Cannabis Use Disorder (CUD). One response to this problem is to develop decision-making constructs that indicate vulnerability to CUD...
Associations of cannabis product source and subsequent cannabis use among adolescents
Abstract Background Cannabis is obtained from a variety retail and illicit sources, with unknown implications for youth cannabis use. This study assessed whether source of obtaining cannabis was associated with future cannabis use among adolescents. Methods...
Characterizing cannabis use reduction and change in functioning during treatment: Initial steps on the path to new clinical endpoints
Abstract Reduction-based cannabis use endpoints are needed to better evaluate treatments for cannabis use disorder (CUD). This exploratory, secondary analysis aimed to characterize cannabis frequency and quantity reduction patterns and corresponding changes in...
Cannabis Use Disorder and Its Treatment
Scientific advances and clinical epidemiology provide clear evidence of cannabis’ potential for addiction and adverse psychosocial and health consequences, yet skepticism about its addictive potential remains, and perceived risk of its potential for harm continues to...